Benign Hematology Program
Penn has one of the few programs in the country selected to particpate in the NHLBI K12 Program. Implemented in
2006, the program's purpose is to develop, implement, and evaluate multidisciplinary career development programs in
non-malignant hematology that will equip new investigators with the knowledge and skills to address complex
problems in blood diseases.
Penn Hematology Scholars
The following are the minimum application requirements of the program:
Possess an M.D. or D.O. degree, or a doctoral degree in a related discipline Be a U.S. citizen, non-citizen national, or permanent resident Commit 75% of full-time professional effort to the program for a minimum of two years Have two mentors and a commitment to a career focused on non-malignant clinical hematology or a specific
blood issue
For more information or to apply, please contact:
Advisory Board for Hematology-Oncology K-12 Grant in Benign Hematology:
Naomi L.C. Luban, MD
Interim Executive Director, The Center for Cancer & Blood Disorders
Director, Hemophilia Treatment Program & Transfusion
Division Chair, Laboratory Medicine
Children's National Medical Center Daniel J. Rader, MD
Associate Professor of Medicine, Pathology & Pharmacology
University of Pennsylvania School of Medicine Arthur H. Rubenstein, MBBCh
Dean, University of Pennsylvania School of Medicine
Executive Vice President
University of Pennsylvania for the Health System Andrew I. Schafer, MD
The E. Hugh Luckey Distinguished Professor of Medicine
Weill-Cornell Medical College
Physician in Chief
NY-Presbyterian Hospital, Weill-Cornell Virginia A. Stallings, MD
Director, Office of Faculty Development
Joseph Stokes Research Institute
The Children's Hospital of Philadelphia
Professor of Pediatrics
University of Pennsylvania School of Medicine
|
